Fol. Biol. 2012, 58, 221-230
https://doi.org/10.14712/fb2012058060221
Efficient Generation of Induced Pluripotent Stem Cells from Human Bone Marrow Mesenchymal Stem Cells
References
1. 2009) Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23, 2134-2139.
< , A., Rashid, S. T., Acosta, J. C., Li, S., Pereira, C. F., Geti, I., Pinho, S., Silva, J. C., Azuara, V., Walsh, M., Vallier, L., Gil, J. (https://doi.org/10.1101/gad.1811609>
2. 2010) Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep. 11, 353-359.
< , A., Gil, J. (https://doi.org/10.1038/embor.2010.47>
3. 2011) Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 21, 518-529.
< , B. K., Mali, P., Huang, X., Ye, Z., Dowey, S. N., Resar, L. M., Zou, C., Zhang, Y. A., Tong, J., Cheng, L. (https://doi.org/10.1038/cr.2011.12>
4. 2010) Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71-79.
< , M. A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., Li, W., Weng, Z., Chen, J., Ni, S., Chen, K., Li, Y., Liu, X., Xu, J., Zhang, S., Li, F., He, W., Labuda, K., Song, Y., Peterbauer, A., Wolbank, S., Redl, H., Zhong, M., Cai, D., Zeng, L., Pei, D. (https://doi.org/10.1016/j.stem.2009.12.001>
5. 2010) Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143, 508-525.
< , J. H., Saha, K., Jaenisch, R. (https://doi.org/10.1016/j.cell.2010.10.008>
6. 2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132-1135.
< , H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., Yamanaka, S. (https://doi.org/10.1038/nature08235>
7. 2008a) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotech. 26, 795-797.
< , D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., Melton, D. A. (https://doi.org/10.1038/nbt1418>
8. 2008b) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotech. 26, 1269-1275.
< , D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., Melton, D.A. (https://doi.org/10.1038/nbt.1502>
9. 2012) Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30, 42-47.
< , Y., Bauer, G., Nolta, J. A. (https://doi.org/10.1002/stem.727>
10. 2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144.
< , T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., Izpisúa Belmonte, J. C. (https://doi.org/10.1038/nature08311>
11. 2009) Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649-643.
< , J. B., Greber, B., Araúzo-Bravo, M. J., Meyer, J., Park, K. I., Zaehres, H., Schöler, H. R. (https://doi.org/10.1038/nature08436>
12. 2010) Apoptotic caspases regulate induction of iPSCs from human fibroblasts. Cell Stem Cell 7, 508-520.
< , F., He, Z., Shen, J., Huang, Q., Li, W., Liu, X., He, Y., Wolf, F., Li, C. Y. (https://doi.org/10.1016/j.stem.2010.09.003>
13. 2010) Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28, 713-720.
< , P., Chou, B.-K., Yen, J., Ye, Z., Zou, J., Dowey, S., Brodsky, R. A., Ohm, J. E., Yu, W., Baylin, S. B., Yusa, K., Bradley, A., Meyers, D. J., Mukherjee, C., Cole, P. A., Cheng, L. (https://doi.org/10.1002/stem.402>
14. 2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotech. 26, 101-106.
< , M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., Yamanaka, S. (https://doi.org/10.1038/nbt1374>
15. 2011) Purified mesenchymal stem cells are an efficient source for iPS cell induction. PLoS ONE 6, e17610.
< , K., Kawamura, Y., Araki, D., Morikawa, S., Miura, K., Suzuki, S., Shimmura, S., Sunabori, T., Mabuchi, Y., Nagai, Y., Nakagawa, T., Okano, H., Matsuzaki, Y. (https://doi.org/10.1371/journal.pone.0017610>
16. 2010) Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J. Biol. Chem. 285, 29270-29278.
< , Y., Yoshimura, Y., Ohnishi, H., Tadokoro, M., Katsube, Y., Sasao, M., Kubo, Y., Hattori, K., Saito, S., Horimoto, K., Yuba, S., Ohgushi, H. (https://doi.org/10.1074/jbc.M109.055889>
17. 2011) A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrowand adipose tissue-derived mesenchymal stem cells. J. Tissue Eng. Regen. Med. 6, 261-271.
< , H., Oda, Y., Aoki, T., Tadokoro, M., Katsube, Y., Ohgushi, H., Hattori, K., Yuba, S. (https://doi.org/10.1002/term.428>
18. 2007) Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317.
< , K., Ichisaka, T., Yamanaka, S. (https://doi.org/10.1038/nature05934>
19. 2011) Induced pluripotent stem cells: opportunities and challenges. Phil. Trans. R. Soc. B 366, 2198-2207.
< , K., Yamanaka, S. (https://doi.org/10.1098/rstb.2011.0016>
20. 2010) Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12, 87-117.
< , B., Milwid, J. M. (https://doi.org/10.1146/annurev-bioeng-070909-105309>
21. 1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
< , M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A,, Simonetti, D. W., Craig, S., Marshak, D. R. (https://doi.org/10.1126/science.284.5411.143>
22. 2009) The molecular mechanism of induced pluripotency: A two-stage switch. Stem Cell Rev. 5, 204-223.
< , W., Copray, S. (https://doi.org/10.1007/s12015-009-9077-x>
23. 2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell 126, 663-676.
, K., Yamanaka, S. (
24. 2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
< , K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S. (https://doi.org/10.1016/j.cell.2007.11.019>
25. 1959) Homografts of bone marrow in dogs after lethal total-body radiation. Blood 14, 720-736.
< , E. D., Ashley, C. A., Lochte, H. L., Jaretzki, A., Sahler, O. D., Ferrebee, J. W. (https://doi.org/10.1182/blood.V14.6.720.720>
26. 2011) Induced pluripotent stem cells for modelling human diseases. Phil. Trans. R. Soc. B 366, 2274-2285.
< , J. J., Daley, G. Q. (https://doi.org/10.1098/rstb.2011.0017>
27. 2009) Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 1145-1148.
< , J., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., Hochedlinger, K. (https://doi.org/10.1038/nature08285>
28. 2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630.
< , L., Manos, P. D., Ahfeldt, T., Loh, Y. H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., Daley, G. Q., Brack, A. S., Collins, J. J., Cowan, C., Schlaeger, T. M., Rossi, D. J. (https://doi.org/10.1016/j.stem.2010.08.012>
29. 2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
< , J., Vodyanik, M. A., Smuga-Otto, K., AntosiewiczBourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, II., Thomson, J. A. (https://doi.org/10.1126/science.1151526>
30. 2008) Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3, 475-479.
< , Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., Zhang, Q., Xiang, C., Hou, P., Song, Z., Liu, Y., Yong, J., Zhang, P., Cai, J., Liu, M., Li, H., Li, Y., Qu, X., Cui, K., Zhang, W., Xiang, T., Wu, Y., Zhao, Y., Liu, C., Yu, C., Yuan, K., Lou, J., Ding, M., Deng, H. (https://doi.org/10.1016/j.stem.2008.10.002>
31. 2010) Evolution of induced pluripotent stem cell technology. Curr. Opin. Hematol. 17, 276-280.
< , H., Ding, S. (https://doi.org/10.1097/MOH.0b013e328339f2ee>